التفاصيل البيبلوغرافية
| العنوان: |
Use of labetalol vs nifedipine in preeclampsia |
| المؤلفون: |
Wardy Castillo López, Izaida Lis Montero López, Adrián Ernesto Díaz Montero, Regla Cristina Valdés Cabodevilla |
| المصدر: |
Gaceta Médica Espirituana, Vol 25, Iss 2 (2023) |
| بيانات النشر: |
Universidad de Ciencias Médicas de Sancti Spíritus, 2023. |
| سنة النشر: |
2023 |
| المجموعة: |
LCC:Medicine (General) |
| مصطلحات موضوعية: |
preeclampsia, hipertensión inducida en el embarazo, labetalol y uso terapéutico, nifedipino y uso terapéutico., Medicine (General), R5-920 |
| الوصف: |
Background: Pre-eclampsia is a generalized vasoconstriction state associated with vascular epithelial dysfunction rather than the vasodilation characteristic of pregnancy, characterized by proteinuric hypertension from the 20th week of pregnancy, sometimes associated with edema; it also causes health risks to the mother and fetus. Traditional clinical treatment uses oral antihypertensive drugs, among these labetalol and extended-release nifedipine are included. Objective: To analyze the efficacy of labetalol and nifedipine as an antihypertensive treatment in pre-eclampsia. Methodology: Reference sources found in Google Scholar, Science Direct, SciELO, Pubmed, Medes and Elsevier were used. Out of 211 sources, 31 were selected according to inclusion and exclusion criteria. Conclusions: It has been determined by majority consensus that oral nifedipine is more effective than labetalol in pre-eclampsia treatment. |
| نوع الوثيقة: |
article |
| وصف الملف: |
electronic resource |
| اللغة: |
Spanish; Castilian |
| تدمد: |
1608-8921 |
| Relation: |
https://revgmespirituana.sld.cu/index.php/gme/article/view/2545; https://doaj.org/toc/1608-8921 |
| URL الوصول: |
https://doaj.org/article/0931eb2fdb64444cb26cd42ae3113536 |
| رقم الانضمام: |
edsdoj.0931eb2fdb64444cb26cd42ae3113536 |
| قاعدة البيانات: |
Directory of Open Access Journals |